Free shipping on all orders over $ 500

 About 1 result found for searched term "1438851-35-4" (0.126 seconds)

Cat.No.  Name Target
M24674 ABP 215 VEGFR/PDGFR
ABP 215 (Bevacizumab-awwb), a Bevacizumab (Bevacizumab biosimilar, is a humanized IgG1 monoclonal antibody targeting VEGFA (VEGFR). ABP 215 has anticancer effects, and can be used metastatic colorectal cancer (mCRC) research.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.